Mechanism of the Anticancer Effect of Phytochemicals (The Enzymes): Volume 37

Mechanism of the Anticancer Effect of Phytochemicals (The Enzymes): Volume 37

by Fuyuhiko Tamanoi (Editor), Fuyuhiko Tamanoi (Editor), S. Zahra Bathaie (Editor)

Synopsis

Volume 37 will provide details on the major chemical constituents of medicinal plants and their mechanism of action as the anticancer compounds. This special issue, in addition to the previous volume (volume 36 of The Enzyme series was on Natural Products and Cancer Signaling Targets: Isoprenoids, Polyphenols and Flavonoids), will highlight the significant advance made in the field in elucidating mechanisms of anticancer effect of the major phytochemicals.

$161.77

Quantity

20+ in stock

More Information

Format: Hardcover
Pages: 276
Publisher: Academic Press
Published: 01 Sep 2015

ISBN 10: 0128038764
ISBN 13: 9780128038765
Book Overview: As with the previous volume, this special issue highlights the significant advance made in the field in elucidating mechanisms of anticancer effect of the major phytochemicals

Author Bio
Fuyu Tamanoi is a biochemist who has served on the UCLA School of Medicine and UCLA College faculty since he joined the Department of Microbiology, Immunology & Molecular Genetics in 1993. He became a full professor in 1997. Since 1996, he has been a Director of Signal Transduction Program Area at Jonsson Comprehensive Cancer Center. Dr. Tamanoi earned his B.S. and M.S. in Biochemistry at the University of Tokyo. He received PhD in Molecular Biology at Nagoya University in 1977. He was a postdoctoral fellow at Harvard Medical School, where he worked on bacteriophage DNA replication. From 1980 to 1985, he was a senior staff investigator at Cold Spring Harbor Laboratory, where he worked on adenovirus DNA replication. From 1985 to 1993, he was an Assistant Professor and then Associate Professor at the University of Chicago, where he initiated studies on lipid modification of the Ras family proteins. His laboratory research centers on signal transduction and signal transduction inhibitors. He is currently exploring ways to deliver signal transduction inhibitors using nanoparticles.